375/20 (Vimovo esomeprazole 20 mg / naproxen 375 mg)
Generic Name: esomeprazole/naproxen
Pill imprint 375/20 has been identified as Vimovo esomeprazole 20 mg / naproxen 375 mg.
Vimovo is used in the treatment of osteoarthritis; ankylosing spondylitis; rheumatoid arthritis; nsaid-induced ulcer prophylaxis and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Vimovo esomeprazole 20 mg / naproxen 375 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- esomeprazole 20 mg / naproxen 375 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule:
- Not a controlled drug
- AstraZeneca Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- carnauba wax
ferric oxide yellow
More about Vimovo (esomeprazole / naproxen)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.